IRVINE, Calif.--ISTA Pharmaceuticals
(Nasdaq: ISTA) plans to offer 4.5 million shares of its common
stock in an underwritten public offering.
ISTA also intends to grant an option to the underwriters to
purchase up to an additional 675,000 shares of common stock to
cover over-allotments, if any. All of the shares are being sold by
the company.
January 2005
Latest News